The loss of RB1 in SCLC results in a disruption of E2F1 inhibition, which subsequently causes a rise in the levels of several key mediators of DDR, including PARP1 and notably the CHK1 protein. This evidence concerns the gene PARP1 and small cell lung carcinoma.